National Surgical Centers Stockton Adds FDA-Approved Procedure to Relieve Painful Diabetic Neuropathy
Retrieved on:
Tuesday, May 9, 2023
Hypersensitivity, Injection, Diabetic neuropathy, PDN, Interventional radiology, Diabetes, Stabbing, Spinal cord, Medicine, Brain, Sensation, Pain, Food and Drug Administration, La Senza, MD, HFX, Freezing, Patient, FDA, Chronic pain, Paresthesia, Food, Safety, Conditional sentence, SCS, Dentistry, Pharmaceutical industry, Medical device
STOCKTON, Calif., May 9, 2023 /PRNewswire/ -- National Surgical Centers Stockton (NSC Stockton), an outpatient surgery center, is now offering high-frequency spinal cord stimulation (SCS) procedure(s) for the treatment of painful diabetic neuropathy (PDN). The technology, called HFX, is made by medical device company NEVRO of Redwood City, Calif. HFX is an FDA-approved, non-drug treatment for PDN and is the only paresthesia-free therapy approved by the FDA to treat painful diabetic neuropathy (PDN) with unrivaled evidence-based outcomes.
Key Points:
- Painful diabetic neuropathy causes pain in the limbs, often managed by medicine that is inadequate for long-term relief
STOCKTON, Calif., May 9, 2023 /PRNewswire/ -- National Surgical Centers Stockton (NSC Stockton), an outpatient surgery center, is now offering high-frequency spinal cord stimulation (SCS) procedure(s) for the treatment of painful diabetic neuropathy (PDN). - "People with painful diabetic neuropathy know it to be a cruel addition to the chronic disease they must fight every day," said B.J.
- Sandhu, MD, Interventional Radiologist at National Surgical Centers Stockton.
- In a recent study, 92% of patients reported high satisfaction with the therapy.4
For important safety information regarding this treatment, please visit www.HFXforPDN.com .